Catalyst Pharmaceuticals Inc CN2.DU Stock
14.05 EUR
{{ price }}
2.107558%
{{change_pct}}%
COUNTRY
Germany
Exchange
Dusseldorf
Market Cap
0 EUR
LOW - HIGH [24H]
13.8
-
14.05 EUR
VOLUME [24H]
22 EUR
{{ volume }}
P/E Ratio
0
Earnings per share
0 EUR
Catalyst Pharmaceuticals Inc Price Chart
Catalyst Pharmaceuticals Inc CN2.DU Financial and Trading Overview
Catalyst Pharmaceuticals Inc stock price | 14.05 EUR |
Previous Close | 11 EUR |
Open | 11.14 EUR |
Bid | 11.24 EUR x N/A |
Ask | 11.47 EUR x N/A |
Day's Range | 11.14 - 11.2 EUR |
52 Week Range | 6.02 - 20.5 EUR |
Volume | 15 EUR |
Avg. Volume | 0 EUR |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
CN2.DU Valuation Measures
Enterprise Value | N/A |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | N/A |
Trading Information
Catalyst Pharmaceuticals Inc Stock Price History
Beta (5Y Monthly) | N/A |
52-Week Change | N/A |
S&P500 52-Week Change | N/A |
52 Week High | 20.5 EUR |
52 Week Low | 6.02 EUR |
50-Day Moving Average | 13.6 EUR |
200-Day Moving Average | 14.56 EUR |
CN2.DU Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | N/A |
Float | N/A |
Short Ratio | N/A |
% Held by Insiders | N/A |
% Held by Institutions | N/A |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | N/A |
Trailing Annual Dividend Yield | N/A |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor | N/A |
Financial Highlights
Fiscal Year
Fiscal Year Ends | N/A |
Most Recent Quarter (mrq) | N/A |
Next Fiscal Year End | N/A |
Profitability
Profit Margin | N/A |
Operating Margin (ttm) | N/A |
Gross Margin | N/A |
EBITDA Margin | N/A |
Management Effectiveness
Return on Assets (ttm) | N/A |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | N/A |
Net Income Avi to Common (ttm) | N/A |
Diluted EPS (ttm) | N/A |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | N/A |
Total Cash Per Share (mrq) | N/A |
Total Debt (mrq) | N/A |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | N/A |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | N/A |
Levered Free Cash Flow (ttm) | N/A |
Q&A For Catalyst Pharmaceuticals Inc Stock
What is a current CN2.DU stock price?
Catalyst Pharmaceuticals Inc CN2.DU stock price today per share is 14.05 EUR.
How to purchase Catalyst Pharmaceuticals Inc stock?
You can buy CN2.DU shares on the Dusseldorf exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Catalyst Pharmaceuticals Inc?
The stock symbol or ticker of Catalyst Pharmaceuticals Inc is CN2.DU.
How many shares does Catalyst Pharmaceuticals Inc have in circulation?
The max supply of Catalyst Pharmaceuticals Inc shares is 0.
What is Catalyst Pharmaceuticals Inc Price to Earnings Ratio (PE Ratio)?
Catalyst Pharmaceuticals Inc PE Ratio is now.
What was Catalyst Pharmaceuticals Inc earnings per share over the trailing 12 months (TTM)?
Catalyst Pharmaceuticals Inc EPS is 0 EUR over the trailing 12 months.